Societe Generale’s Pediatrix Medical MD Stock Holding History

Societe Generale’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$3.86M	Buy	+53,305	New	+$3.66M	0.03%	480

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Societe Generale's MD Position: Q2 2016 in Review

Societe Generale opened a new position in Pediatrix Medical (MD) in Q2 2016: 53,305 shares worth $3.86M. The stake represents 0.03% of the portfolio and ranks #480 among its holdings.

391 funds tracked by Wall St. Rank hold MD as of Q2 2016.

Societe Generale held 53,305 shares of Pediatrix Medical worth $3.86M as of Q2 2016.
Pediatrix Medical was a new Societe Generale position in Q2 2016.
Pediatrix Medical made up 0.03% of Societe Generale's portfolio in Q2 2016, its #480 holding.
391 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.